Clinical Trial Detail

NCT ID NCT02918162
Title Perioperative Chemo and Pembrolizumab in Gastric Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Paul Oberstein
Indications

gastroesophageal junction adenocarcinoma

gastric adenocarcinoma

Therapies

Capecitabine + Epirubicin + Oxaliplatin + Pembrolizumab

Age Groups: senior adult

No variant requirements are available.